Tesamorelin vs Sermorelin: which has stronger proof?
Both copy a body signal. Their length differs, and one resists faster breakdown. The larger gap is in the human studies.
What is the main tesamorelin vs sermorelin difference?
Drug makers copied the same natural growth message twice. Tesamorelin and sermorelin both came from that work. Both make a gland under the brain send growth hormone into blood.
Tesamorelin uses all forty-four amino acids from that body-made message. One end is changed so it won’t break down fast. Sermorelin uses a shorter set of twenty-nine amino acids [8].
Sermorelin lacks that added cover. Tesamorelin also has large trials in adults with HIV. This page doesn’t claim the same proof for sermorelin.
Why do 44 amino acids differ from 29?
Length is the easiest difference to see. Tesamorelin has all 44 protein parts from the natural message. Sermorelin uses the first 29 parts [8].
Both keep the part that talks to the gland under the brain. The drugs aren’t the same size. Size alone doesn’t tell you how well either one works.
Researchers also changed tesamorelin’s first end [8]. Sermorelin doesn’t have that added cover. The cover slows the body’s normal breakdown of tesamorelin.
That is why tesamorelin outlasts the natural message. The studies compare the drugs by length and breakdown. A long written formula adds no useful health fact.
Why does tesamorelin’s signal last longer?
The body soon starts breaking down its natural growth message. The work begins near one end after the message enters blood.
Tesamorelin’s added cover slows that first break [8]. Sermorelin doesn’t have the same cover. Researchers meant the change to keep tesamorelin active longer.
The change gives the gland under the brain more time to answer [16]. Tesamorelin leaves blood in minutes. IGF-1, its liver-made growth signal, still lasts between shots [16].
The tesamorelin trials measured that longer liver response. They didn’t test whether sermorelin’s IGF-1 response lasts as long. The two study records remain separate.
Which drug has more human study results?
Tesamorelin has the larger set of human trials here. Two main Phase 3 trials measured deep belly fat. Other studies checked liver fat and body signals.
A 2026 review joined five trials. That work backed approval in 2010 for one HIV use [1][3][4][5][13]. This page has no matching set of sermorelin trials.
In the main trial, 2 mg daily cut deep belly fat 15.2%. IGF-1, the liver growth signal, rose 81% [1]. The 2026 review reported a drop in deep belly fat.
The review reported less liver fat too [13]. The next check marked 140 square centimeters as its cutoff for deep belly fat. That wasn’t a care goal. More people on tesamorelin finished below it [11].
Those results belong to tesamorelin. They don’t tell you what sermorelin would do. The drugs differ in length and at their first end [8].
Both cause the gland under the brain to send out growth hormone. Their amount of proof isn’t equal. See how tesamorelin works for the shared first step.
What do both drugs do, and which one is approved?
Both drugs act on the same gland under the brain [4][6]. They prompt that gland to release growth hormone. Neither drug supplies growth hormone itself. That shared first step is why people compare them.
Tesamorelin is approved for one HIV belly-fat problem [5][14]. Sermorelin doesn’t share that approval. Other tesamorelin uses aren’t approved either.
Sports rules also bar tesamorelin. Online powder marked for lab research isn’t the approved drug. It isn’t cleared for people to use on themselves.